Clinical Trials Logo

High Blood Pressure clinical trials

View clinical trials related to High Blood Pressure.

Filter by:

NCT ID: NCT04403789 Completed - Clinical trials for Cardiovascular Risk Factor

Effects of a Workplace Exercise Intervention on Cardio-Metabolic Health

Start date: March 28, 2021
Phase: N/A
Study type: Interventional

Background: The rising levels of physical inactivity in the Eastern Mediterranean region (43.2%) and in the United Arab Emirates (38%) compared with the global levels of physical inactivity (31.2%) is alarming (6,15). Therefore, action is required to reduce physical inactivity using evidence-based strategies. This study aims to provide scientific evidence that if the workplace environment promotes behavior change, physical activity levels could increase and, therefore, improve health. Objective: Primary objective: to determine whether the workplace exercise intervention will improve the cardio-metabolic risk components for the employees. Secondary objective: to determine whether the workplace exercise intervention will improve physical activity levels even after 4 weeks of completing the intervention. Methods: A total of 150 participants will be recruited from a semi-government telecommunication company after meeting the eligibility criteria; 75 will be assigned to the intervention group and 75 to the delayed intervention group. Intervention: The Intervention group will receive 2 hours of exercise per week during working hours for 12 weeks. One hour can be used per day. The intervention group will be assigned to attend personal trainer sessions in the workplace gym during the intervention. After the intervention is completed the delayed intervention group will also receive 2 hours of exercise time per week from working hours for 4 weeks. Expected results: There is a statistically significant difference in the primary and secondary health outcome between the intervention group and delayed intervention group. Expected conclusion: Increasing exercise time in the workplace is associated with favorable cardio-metabolic risk profile.

NCT ID: NCT04317690 Completed - Breast Cancer Clinical Trials

Online Trial Examining Validity and Reliability of the Shared Decision Making Process Survey

Start date: March 17, 2020
Phase:
Study type: Observational

The purpose of this study is to survey a sample of adults who have recently made a decision about treatment of high cholesterol or high blood pressure or a decision about screening for colorectal cancer, breast cancer, or prostate cancer. The main goal is to gather evidence of the validity and reliability of the Shared Decision Making Process scale. Secondary goal is to gather evidence on the quality of decisions for these common medical situations.

NCT ID: NCT04105192 Completed - Clinical trials for Overweight and Obesity

Effectiveness of a Natural Ingredient on Obesity

(RACO)
Start date: March 1, 2019
Phase: N/A
Study type: Interventional

randomized, placebo-controlled clinical trial, with two parallel branches whose objective is to evaluate the efficacy of the product investigated on blood pressure and fat mass of subjects without pharmacotherapy.

NCT ID: NCT04084574 Completed - Clinical trials for Chronic Kidney Diseases

Diet and Hypertension Management in African Americans With Chronic Kidney Disease

Start date: April 14, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to determine cultural and disease-related barriers and facilitators to following the Dietary Approaches to Stop Hypertension (DASH) dietary pattern among Black Americans with moderate chronic kidney disease (CKD) and test the impact of a behavioral diet counseling intervention on DASH diet adherence, blood pressure, and CKD-relevant outcomes.

NCT ID: NCT04082819 Completed - Hypertension Clinical Trials

MediBeat - HeartBeat Observation Trial

Start date: October 4, 2019
Phase: N/A
Study type: Interventional

The goal of the study was to compare the current gold standard blood pressure instrument (a mercury-filled sphygmomanometer with cuff and stethoscope) with the new experimental algorithm developed by HeartBeat Technologies Ltd. To that end, participants were recruited from Markham, Ontario and participated in a series of alternating blood pressure measurements over a period of 45 minutes. Comparisons were made between manual measurements and device measurements to determine the quality of the device readings. Measurements were taken by trained nurses and staff were consistent across the study duration.

NCT ID: NCT03937934 Completed - Obesity Clinical Trials

Study Title: Food Rx

Start date: May 20, 2019
Phase: N/A
Study type: Interventional

Researchers are trying to determine if subjects with lack of access to healthy food and a long term health problem, are helped by a weekly box of healthy groceries and nutrition education.

NCT ID: NCT03812614 Completed - Hypertension Clinical Trials

Comparative Effectiveness of Family vs. Individually Focused Diabetes Education and Support

Start date: September 23, 2019
Phase: N/A
Study type: Interventional

The objective of this study is to compare the effectiveness of a novel program-Family Support for Health Action (FAM-ACT) - to individual patient-focused diabetes self-management education and support (I-DSMES).

NCT ID: NCT03726710 Completed - Hypertension Clinical Trials

Cut Your Blood Pressure 3

Start date: November 1, 2018
Phase: N/A
Study type: Interventional

The recently published LA Barbershop in the New England Journal of Medicine (Victor et al. N Engl J Med 2018; 378: 1291-301) solid evidence of the efficacy of a pharmacist-led medication management intervention to reduce blood pressure in black men that patronize barbershops. One of the most significant logistical inefficiencies of the LA Barbershop Study was the amount of time the pharmacists spent driving for face-to-face visits with participants. On average, each round trip was 40 miles and pharmacists drove 2 hours per day. By using telemedicine, the study team can minimize the number of face-to-face in-person visits and increase pharmacist efficiency by 25%. the study team aim to increase the scalability of our novel, evidence-based barbershop model by addressing this inefficiency with the pilot study. In the LA Barbershop trial, each participant averaged 7 in-person visits in 6 months. the study team found that the initial in-person visits between the pharmacist, barber, and patron were essential for establishing trust as well as obtaining baseline electrolyte and serum creatinine levels (with our validated point-of-care device, iSTAT). However, once rapport has been established and blood pressure control achieved, the study team postulate that the effect can be maintained remotely with telemedicine. Our data indicate that most patients' can achieve their blood pressure goal in 3 months or less. the study team propose replacing additional in-person visits with telemonitoring (via Skype or FaceTime) at this juncture, provided blood chemistries are stable. the study team plan to pilot this in 20 patients from 2 to 3 barbershops for 12 months.

NCT ID: NCT03700710 Completed - Clinical trials for Overweight and Obesity

Remote Dietary Counseling to Promote Healthy Diet and Blood Pressure

Start date: January 16, 2019
Phase: N/A
Study type: Interventional

American College of Cardiology/American Heart Association (ACC/AHA) hypertension guidelines recommend lifestyle modification for patients with elevated blood pressure. While eating a Dietary Approaches to Stop Hypertension (DASH)-type diet, increasing physical activity, and weight loss have been shown to reduce blood pressure, limited resources are available in the primary care setting to help patients make these changes. In this study, the investigators will compare the efficacy of a self-guided vs. dietitian-led approach using web-based lifestyle modification tools to reduce weight, improve dietary quality, and lower blood pressure in overweight/obese adults with elevated blood pressure.

NCT ID: NCT03650166 Completed - High Blood Pressure Clinical Trials

High BP and Home Monitoring Experience (HoME) Study

HoME
Start date: September 21, 2018
Phase: N/A
Study type: Interventional

High blood pressure is a leading risk factor for cardiovascular and kidney disease, yet is uncontrolled in half of affected individuals, and specifically older adults. The investigators have developed an automated program for patient education and personalized assistance of systematic home BP self-monitoring. Reports are sent to primary care providers at regular intervals. This investigation will collect pilot data on feasibility and effectiveness in older adults with and without a caregiver.